AI assistant
Median Technologies — Share Issue/Capital Change 2022
Nov 8, 2022
1514_dva_2022-11-08_c65c1169-dbc6-4fe1-9cc0-93e24e0f895e.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Press release – For immediate release November 8 th , 2022 – 5:45 pm CET
Disclosure of total number of voting rights and number of shares in the capital as of October 31st, 2022
Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Sophia Antipolis, France
| Total number of shares | 15,525,699 |
|---|---|
| Number of real voting rights (excluding treasury shares*) |
15,479,647 |
| Theoretical number of voting rights (including treasury shares*) |
15,502,499 |
(*) Class E preference shares are non-voting
(**) pursuant to article 223-11 of the AMF's General Regulations
About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy®, our AI-powered software as medical device help biopharmaceutical companies
and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label "Innovative company" by the BPI France and is listed on Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME), is listed on the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: www.mediantechnologies.com
Contacts
| Median Technologies | Press - ALIZE RP | Investors - ACTIFIN |
|---|---|---|
| Emmanuelle Leygues | Caroline Carmagnol | Ghislaine Gasparetto |
| Head of Corporate Marketing & Financial Communications | +33 6 64 18 99 59 | +33 6 21 10 49 24 |
| +33 6 10 93 58 88 | [email protected] | [email protected] |
| [email protected] |